ClinicalTrials.gg
RecruitingNCT05151965Updated Apr 2, 2024

Return to Sport and Functional Performance Following Surgical Intervention for Anterior Glenohumeral Instability

An observational study in Anterior Shoulder Dislocation and Anterior Shoulder Instability, sponsored by Panam Clinic. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-04-02.

Sponsored by Panam Clinic · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Sep 2022; still recruiting 4 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
72
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The purpose of this prospective cohort study is to compare patient-reported, clinical, and functional outcomes in patients who have elected to have either the Bankart with Remplissage or Latarjet procedure for the treatment of anterior glenohumeral instability (AGHI) up to 24-months postoperative.

Read the detailed description

The purpose of this prospective cohort study is to compare patient-reported, clinical, and functional outcomes in patients who have elected to have either the Bankart with Remplissage or Latarjet procedure for the treatment of AGHI up to 24-months postoperative. A secondary objective aims to address rates of return to sport (RTS) and performance in an RTS assessment in athletic patients with anterior glenohumeral instability (AGHI) who elect to undergo either surgical intervention until 24-months postoperative.

02

Conditions studied

  • Anterior Shoulder Dislocation
  • Anterior Shoulder Instability

Browse trials for

Keywords

  • Bankart repair
  • Remplissage
  • Latarjet Coracoid Transfer
  • Return to sport
03

In context

Shoulder Dislocation

105 studies on the registry are indexed under Shoulder Dislocation; 22 are open to participants now.

This study's planned enrollment of 72 is below the median of 86 across 28 observational studies indexed under Shoulder Dislocation.

Browse Shoulder Dislocation studies →

Lead sponsor

Panam Clinic is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 18 - 50 years who have documented reduction of anterior shoulder dislocation. The participant has suffered two or more dislocations of the study shoulder, and the physical examination elicits unwanted glenohumeral translation with reproduction of symptoms. The participant has glenoid bone loss defined on CT (or MRI) using standardized and reproducible best-fit circle techniques \< 25%, and would benefit from surgical intervention.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 - 50 years
  • Documented reduction of anterior shoulder dislocation
  • Patient has suffered two or more dislocations of the study shoulder
  • Physical examination elicits unwanted glenohumeral translation with reproduction of symptoms
  • Glenoid bone loss defined on CT (or MRI) using standardized and reproducible best-fit circle techniques \< 25%
  • Able to benefit from surgical intervention

Exclusion criteria

Exclusion Criteria:

  • Glenoid defect in the affected shoulder ≥ 25% of the AP diameter of the glenoid
  • Previous surgery on affected shoulder (ANY type of shoulder surgery)
  • Significant shoulder comorbidities including osteoarthritis or other shoulder conditions including multi-directional instability
  • Participant is involved in litigation or a workplace insurance claim (i.e., WCB).
  • Confirmed connective tissue disorder (i.e., Ehlers-Danlos, Marfans)
  • Beighton hypermobility score of >6
  • Active joint or systemic infection, significant muscle paralysis, rotator cuff tear arthropathy, Charcot's arthropathy, significant medical comorbidity that could alter the effectiveness of the surgical intervention (e.g., Cervical radiculopathy, polymyalgia rheumatica)
  • Major medical illness ( less than 1 year) or unacceptably high operative risk
  • Epilepsy
  • Any condition that precludes (i.e. psychiatric illness)
  • Unable to speak or read English/French
  • Unable or unwilling to be followed for 2 years or complete functional testing
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
72 participants (estimated)
Patient registry
No

Groups and cohorts

  • Bankart Repair and Remplissage

    Patients will undergo a standard arthroscopic anterior labral repair with a minimum of 3 suture anchors, followed by remplissage with 1 or 2 anchors, at the discretion of the treating surgeon.

    Procedure: Bankart Repair and Remplissage

  • Latarjet Coracoid Transfer

    Patients will undergo a Latarjet coracoid transfer through a deltopectoral approach and horizontal split in the subscapularis at the superior 2/3, inferior 1/3 junction. The coracoid process will be oriented in the conventional manner, with the inferior surface against the glenoid vault, secured with two cannulated screws

    Procedure: Latarjet Coracoid Transfer

Interventions

  • ProcedureBankart Repair and Remplissage

    Arthroscopic Bankart repair with a minimum of 3 anchors 1 or 2 anchor Remplissage subsequently performed with percutaneous anchor insertion in the base of the Hill-Sachs defect, and sutures passed in a horizontal mattress configuration 1 cm apart, tied in the subacromial space.

  • ProcedureLatarjet Coracoid Transfer

    Coracoid transfer performed via deltopectoral approach with horizontal subscapularis split. Graft placed in the conventional orientation, secured with 2 screws, ensuring the graft is not lateral to the glenoid rim.

06

What researchers measure

Primary outcomes

  1. Western Ontario Shoulder Instability Index (WOSI)

    Is a disease specific, quality of life patient reported outcome measures (PROMS) for patients with shoulder instability. Patients use visual analog scales (VAS) to rate physical symptoms and impacts of the condition/treatment on sports/recreation/work, lifestyle, and emotions.

    Time frame: 24 months

  2. Shoulder dislocation and recurrence

    Dislocation requiring reduction by a physician (ED) or surgery. Dislocations will be identified in two ways: 1) if the patient seeks treatment from the surgeon, the surgeon will notify the research coordinator who will document it accordingly, or 2) at each research postoperative examination, the research staff will ask patients if they experienced a dislocation or subluxation. These will be considered alongside the definition of recurrence from Kasik et al. that also includes subluxation, or positive findings during physical examination for shoulder instability (apprehension).

    Time frame: 24 months

  3. Surgical complications, re-operations and revision surgeries

    Surgical complications will be documented at the time of surgery and at each postoperative interval. A surgical complication is defined as any undesirable, unintended and direct result of an operation affecting the patient that would not have occurred had the operation gone well as could reasonably be hoped (Sokol and Wilson, 2008) (i.e., infection, dislocation, neurological injury, and fracture (including periprosthetic and acromial fracture). Revision surgery and re-operations will be documented, including the reason for failure, date of revision/reoperation, and the procedure performed. Revision is defined as a change of an original component (partial or complete replacement). Re-operation is defined as any surgical procedure other than a revision.

    Time frame: 24 months

Secondary outcomes

  1. Isokinetic Internal and External Rotation

    Internal and external rotation strength will be determined with an isokinetic dynamometer (Biodex Medical Systems, Shirley, NY, USA). With the arm in 90 degrees shoulder abduction and elbow flexion and positioned in the scapular plane, patients will complete coupled concentric and eccentric shoulder internal and external rotation within a 90 degrees range of motion (-40 degrees internal rotation to 50 degrees external rotations). Three maximal effort (instructed to contract as hard and as fast as they can) repetitions will be completed at velocities of 60 and 180 degrees per second, with one-minute rest between testing speeds. Average peak torque of the three repetitions will be recorded for both IR and ER.

    Time frame: 24 months

  2. Athletic Shoulder (ASH) Test

    The patient Is positioned prone with a foam block in place to support their forehand. The test is completed in three positions termed "I", with the arm positioned in 180 degrees of shoulder flexion, "Y, with the arm positioned in 135 degrees of shoulder abduction, and "T", with the arm positioned in 90 degrees of abduction. In each position, the palm of the hand rests on a force plate (AMTI, MA, USA). The patient will complete a warm-up of two submaximal attempts in each position to 80-90% maximal effort, then three maximal effort trials for each limb in each test position (I, Y, T), with 20 seconds rest between repetitions. For each repetition, subjects will be instructed to push against the plate as hard and as fast as possible for three seconds. Peak and mean force across the three attempts and positions will be recorded.

    Time frame: 24 months

  3. Seated medicine ball toss

    The patient will start the test in the seated position with the legs extended in front of their body, and the head, shoulders and back firmly against a wall. They will then attempt a "chest pass" by throwing a 10 lbs. medicine ball as far as they can. Four trials will be completed with 30 sec rest between each trial. Maximum distance will be recorded and averaged, once adjusted for arm length (distance of the ball from the wall with the arm held at 90 degrees of flexion and full elbow extension).

    Time frame: 24 months

  4. Posterior Shoulder Endurance Test

    The patient starts positioned in prone towards one edge of a plinth, with the arm held in 90o shoulder flexion, perpendicular to the floor. Holding a weight of 2% of total body weight, the patient will attempt to raise the weight to 90 degrees of horizontal abduction, holding for one second at this position before returning to the starting position (tempo of 30 bpm). The test is terminated when the patient is fatigued as indicated by 1) the inability to hold the mid position for one second and 2) using compensatory movements of the torso, or patient request to terminate.

    Time frame: 24 months

  5. Plyometric Push up

    Participants will start in a push up position with each hand extended in front of the shoulders and positioned on an individual force plate. When cued, the participant will lower their body to the ground by flexing at the elbow until their sternum is 3 cm from the floor. They will then forcefully extend at the elbow and propel their body into the air above the plate. During landing, the subjects will be instructed to reduce the impact as much as possible and continue for two additional repetitions. Three repetitions will be completed. Peak ground reaction forces during impact, peak rate of force development (RFD) during the concentric phase will be averaged from the three repetitions and expressed as a limb symmetry index (injured/uninjured \* 100%).

    Time frame: 24 months

  6. Single arm seated shot put

    The patient will start seated in an 18" chair without arm rests, with the legs positioned in front of their body, extended to rest straight onto an additional chair. The non-throwing arm will be placed across the chest, with a strap placed diagonally around the upper body to secure the subject to the chair. The patient will "put" (like shot put), and not "throw" (like baseball) the 6 lb. ball from shoulder height for maximal distance. Three maximal effort attempts will be recorded after a graded warm-up of four "puts" at 25, 50, 75 and 100% estimated effort. Thirty seconds rest will be provided between maximal attempts.

    Time frame: 24 months

Other outcomes

  1. American Shoulder and Elbow Surgeons Standardized Shoulder Assessment form (ASES)

    The ASES is a patient-reported upper extremity functional assessment tool and is scored out of a maximum 100 points, that represents maximum function and no pain.

    Time frame: 24 months

  2. Single Assessment Numeric Evaluation (SANE) score

    Is a single question that asks patients to rate their affected shoulder as a percentage of normal, "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"

    Time frame: 24 months

  3. EuroQol-5D (EQ-5D) + Visual Analog Scale (VAS)

    The EQ-5D is a PROM used to document overall wellness across five dimensions including mobility, self-care, usual activities, pain and anxiety/depression. A single value is calculated to represent the patients' health state relative to a specific population. The VAS asks participants: We would like you to indicate on this scale how good or bad your own health is TODAY, in your opinion. 100 means the best health you can imagine. 0 means worst health you can imagine.

    Time frame: 24 months

  4. Shoulder activity scale (SAS)

    A patient reported outcome measure (PROM) where patients categorize the frequency (i.e. never, once a month, once a week, more than once a week, and daily) of certain activities of the upper extremity (i.e. carrying objects 8 lbs. or heavier by hand) and also identify whether they participate in either contact or overhead sports including the level of participation.

    Time frame: 24 months

  5. Postoperative Pain and Medication Use

    Postoperative pain will be self-reported on a 100mm visual analogue scale (VAS) in a logbook. Medication type and quantity will also be documented. The Postoperative Pain and Medication Logbook has been previously used by the authors in an ACL population.

    Time frame: 3 weeks

  6. Subjective Patient Outcome for Return to Sports (SPORTS)

    Evaluates the ability of an athlete to resume their sport at-pre-injury level of training or performance, and whether each is possible without or despite pain. Scored on a 10-point scale, where an inability to return to the same sport is scored as "0" and unlimited effort and performance without pain is a "10".

    Time frame: 24 months

  7. Shoulder Instability Return to Sport (SIRSI)

    PROM of psychological readiness to return-to-sport (RTS), adapted from the previously validated ACL-RSI, that may highlight clinically important differences in patient's perceptions relative to RTS between the two procedures. The SIRSI asks participants 12 questions where they rate on a 10-point scale; "0" is not confident at all, and "10" is fully confident.

    Time frame: 24 months

  8. Waterloo Handedness Questionnaire (WHQ)

    A series of 39 questions used to establish limb dominance, where questions 1-36 ask the participant to indicate their hand preference for the following activities by circling the appropriate response. If they always (i.e. 95% or more of the time) use one hand to perform the described activity, circle Ra or La (for right always or left always). If they usually (i.e. about 75% of the time) use one hand circle Ru or Lu, as appropriate. If they use both hands equally often (i.e. you use each hand about 50% of the time), circle Eq. Questions 37-39 are 'Yes" or "No" answers.

    Time frame: 24 months

  9. Closed Kinetic Chain Upper Extremity Stability Test

    The patient assumes a standard push-up position with the middle of the hands positioned on a 1.5" piece of athletic tape, with 36" between each piece of tape. The patient then alternates lifting each hand to touch the opposite hand/tape as many times as possible within 15 seconds. Three trials will be completed and averaged. Thirty seconds rest will be provided between trials.

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share IPD with other researchers.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2022 (actual). Primary completion is estimated for Apr 2026, 43 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2021
First posted
Dec 9, 2021
StartActual
Sep 1, 2022
Primary completionEst.
Apr 1, 2026
CompletionEst.
Apr 1, 2026
Last update
Apr 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05151965
Lead sponsor
Panam Clinic
Responsible party
Sponsor
First posted
Dec 9, 2021
Start date
Sep 1, 2022
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Apr 2, 2024

Study contacts

Dan Ogborn, PhD
Contact
dogborn@panamclinic.com
204-927-2829
Sheila McRae, PhD
Contact
smcrae@panamclinic.com
204-925-7469
Dan Ogborn, PhD
principal investigator · Pan Am Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion